Read short summaries of the latest oncology-focused peer-reviewed literature published bi-weekly by Oncotarget.
Oncotarget’s Volume 12, Issue #2
New Publications
Cover Paper: Improved therapeutic efficacy of unmodified anti-tumor antibodies by immune checkpoint blockade and kinase targeted therapy in mouse models of melanoma
Origin: New York, United States
Institutions: Columbia University
Quote: “We postulate that combining anti-tumor antibodies with standard-of-care strategies such as immune checkpoint blockade or targeted therapy, will improve therapeutic outcomes in cancer.”
Research Perspective: Clinical application of liquid biopsies to detect somatic BRCA1/2 mutations and guide potential therapeutic intervention for patients with metastatic breast cancer
Origin: Massachusetts, United States
Institution: Harvard Medical School
Quote: “In this article, we discuss recent studies using cell-free DNA testing to identify and classify somatic BRCA1/2 mutations in metastatic breast cancer, and potential future applications for the treatment of metastatic breast cancer.“
Research Paper: A priori prediction of response in multicentre locally advanced breast cancer (LABC) patients using quantitative ultrasound and derivative texture methods
Origin: Ontario, Canada; Texas, United States
Institution: Sunnybrook Health Sciences Centre, University of Toronto, Sunnybrook Research Institute, University Health Network, Western University, Ryerson University, University of Texas
Quote: “We develop a multi-centric response predictive model using QUS spectral parametric imaging and novel texture-derivate methods for determining tumour responses to neoadjuvant chemotherapy (NAC) prior to therapy initiation.“
Research Paper: Harmonized pretreatment quantitative volume-based FDG-PET/CT parameters for prognosis of stage I–III breast cancer: Multicenter study
Origin: Hyogo, Maebashi, Osaka, Tokyo, Japan
Institutions: Hyogo College of Medicine, Nippon Medical School Hospital, National Cancer Center Hospital, Kinki University Faculty of Medicine, Gunma Prefectural College of Health Sciences
Quote: “This study investigated harmonized pretreatment volume-based quantitative FDG-PET/CT parameters in breast cancer patients for prognostic value.“
Review: Reversing oncogenic transformation with iron chelation
Origin: Newcastle upon Tyne, United Kingdom
Institution: Northumbria University
Quote: “This review will evaluate the impact of iron chelation on cancer cell survival and the underlying mechanisms of action.”
Case Report: Standardized diagnostic algorithm for spitzoid lesions aids clinical decision-making and management: a case series from a Swiss reference center
Origin: Zurich, Switzerland
Institution: University Hospital Zurich, Children’s Hospital Zurich
Quote: “We illustrate how clinical, histological and molecular features contribute to an optimized management plan in these critical situations and present a possible algorithm for the assessment of spitzoid neoplasms.“
Click here to read Oncotarget’s Volume 12, Issue #2.
—
Oncotarget is a unique platform designed to house scientific studies in a journal format that is available for anyone to read—without a paywall making access more difficult. This means information that has the potential to benefit our societies from the inside out can be shared with friends, neighbors, colleagues, and other researchers, far and wide.
For media inquiries, please contact media@impactjournals.com.
